» Articles » PMID: 32252500

A Study of Drynaria Fortunei in Modulation of BMP–2 Signalling by Bone Tissue Engineering

Overview
Journal Turk J Med Sci
Specialty General Medicine
Date 2020 Apr 8
PMID 32252500
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Drynaria fortunei (Gusuibu; GSB) is a popular traditional Chinese medicine used for bone repair. An increasing number of studies have reported that GSB induces osteogenic differentiation in bone marrow mesenchymal stem cells (BMSCs). These results provide insight into the application of GSB for bone tissue engineering techniques used to repair large bone defects. However, few studies have described the molecular mechanisms of GSB.

Materials And Methods: In the present study, the effects of GSB and naringin, a marker compound, on the binding of BMP-2 to BMPR and BMP-2-derived signal transduction were investigated using surface plasmon resonance (SPR) and coculturing with BMPR- expressed cell line, C2C12, respectively. Furthermore, naringin was also used to prepare naringin contained scaffolds for bone tissue engineering. The physical and chemical properties of these scaffolds were analysed using scanning electron microscopy (SEM) and highperformance liquid chromatography (HPLC). These scaffolds were cocultured with rabbit BMSCs in vitro and implanted into rabbit calvarial defects for bone repair assessment.

Results: The results showed that GSB and naringin affect the binding of BMP and BMPR in SPR experiments. GSB is a subtle BMP modulator that simultaneously inhibits the binding of BMP-2 to BMPR-1A and enhances its binding to BMPR-1B. In contrast, naringin inhibited BMP-2 binding to BMPR-1A. In vitro studies involving the phosphorylation of signals downstream of BMPR and Smad showed that GSB and naringin affected stem cell differentiation by inhibiting BMPR-1A signalling. When using GSB for bone tissue engineering, naringin exhibited a higher capacity for slow and gradual release from the scaffold, which promotes bone formation via osteoinduction. Moreover, control and naringin scaffolds were implanted into rabbit calvarial defects for 4 weeks, and naringin enhanced bone regeneration in vivo significantly.

Conclusions: GSB and its marker compound (naringin) could inhibit the binding of BMP-2 and BMPR-1A to control cell differentiation by blocked BMPR-1A signalling and enhanced BMPR-1B signalling. GSB and naringin could be good natural BMP regulators for bone tissue engineering.

Citing Articles

Using network pharmacology and molecular docking technology, proteomics and experiments were used to verify the effect of Yigu decoction (YGD) on the expression of key genes in osteoporotic mice.

Yan K, Zhang R, Wang J, Chen H, Zhang Y, Cheng F Ann Med. 2025; 57(1):2449225.

PMID: 39749683 PMC: 11703118. DOI: 10.1080/07853890.2024.2449225.


The role of current herbal extracts in bone regeneration through dental implants: //clinical studies.

Eftekhar Ashtiani R, Hadi A, Nouri F, Rahimi S, Badkoobeh A, Abbasi K Arch Med Sci. 2023; 19(6):1653-1661.

PMID: 38058728 PMC: 10696976. DOI: 10.5114/aoms/153510.


The Development of Naringin for Use against Bone and Cartilage Disorders.

Gan J, Deng X, Le Y, Lai J, Liao X Molecules. 2023; 28(9).

PMID: 37175126 PMC: 10180405. DOI: 10.3390/molecules28093716.


Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis.

Huang A, Xiong Z, Liu K, Chang Y, Shu L, Gao G Front Pharmacol. 2022; 13:1011561.

PMID: 36210811 PMC: 9539404. DOI: 10.3389/fphar.2022.1011561.


A Tumor Accelerator Based on Multicomponent Bone Scaffolds and Cancer Cell Homing.

Huang C, Chou P, Sher Z, Chen Y, Chen T, Dong G Polymers (Basel). 2022; 14(16).

PMID: 36015599 PMC: 9416103. DOI: 10.3390/polym14163340.


References
1.
Yang A, Yu C, Lu Q, Li H, Li Z, He C . Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells. Stem Cells Int. 2019; 2019:5747298. PMC: 6476003. DOI: 10.1155/2019/5747298. View

2.
Chen D, Ji X, Harris M, Feng J, Karsenty G, Celeste A . Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol. 1998; 142(1):295-305. PMC: 2133031. DOI: 10.1083/jcb.142.1.295. View

3.
Wu J, Fong Y, Tsai H, Chen Y, Tsuzuki M, Tang C . Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts. Eur J Pharmacol. 2008; 588(2-3):333-41. DOI: 10.1016/j.ejphar.2008.04.030. View

4.
Zhu Y, Zhang B, Qi Y, Liu H, Zhang Z, Li X . [Microscopic authentication method of traditional Chinese medicine Gusuibu]. Zhongguo Zhong Yao Za Zhi. 2012; 37(8):1152-6. View

5.
Dokuyucu R, Demir T, Yumrutas Onder , Erbagci A, Orkmez M, Bahar A . The role of hepcidin and its related genes (BMP6, GDF-15, and HJV) in rats exposed to ischemia and reperfusion. Turk J Med Sci. 2015; 44(4):576-81. View